C3 and systemic lupus erythematosus: Autoantibody titers (anti-dsDNA), complement proteins (C3 and C4), patient-reported fatigue, and disease activity as determined by the systemic lupus erythematosus disease activity index (SLEDAI) were the main outcomes evaluated.